Ozempic was originally approved to treat people with Type 2 diabetes, but demand has surged because of the drug’s weight-loss ...

Gilead continues its divergence out of its original infectious disease beginnings and into cancer and now, more deeply than ...

From being attacked by being paid $10K to cancel a wedding, these stories prove that sometimes people will believe anything.

Safety Shot, Inc. (NASDAQ: SHOT) announced a significant development with its proposed acquisition of Yerbaé Brands Corp., a plant-based functional beverage company. The news came as Yerbaé disclosed ...